Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 15 | N/A | N/A |
| Other current assets | 200 | 0 | 0 | 0 |
| TOTAL | $204 | $19 | $N/A | $N/A |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $204 | $19 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 986 | 460 | N/A | N/A |
| Accounts payable and accrued liabilities | 193 | 430 | 0 | 0 |
| Accrued Expenses | 168 | 13 | N/A | N/A |
| TOTAL | $2,875 | $903 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,875 | $903 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 9 | 8 | N/A | N/A |
| Retained earnings | -5,922 | -3,658 | N/A | N/A |
| TOTAL | $-2,671 | $-884 | $N/A | $N/A |
| Total Liabilities And Equity | $204 | $19 | $0 | $0 |